Casandra
Casandra Test Code QD57222Version 1 (DRAFT)
Performing Lab
Procainamide and NAPA, Serum
Clinical Use
Order TestUse
Procainamide is used to treat a variety of atrial and ventricular arrhythmias. Metabolism of procainamide produces an active metabolite, N‑Acetylprocainamide (NAPA). The concentration of both procainamide and NAPA levels are monitored to assure adequate therapeutic levels of procainamide are achieved and to avoid toxicity.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
New York Approved
Methodology
Immunoassay
Biomarkers
N‑acetylprocainamide (NAPA)
AnalyteN‑acetylprocainamide (NAPA) • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Procainamide
AnalyteProcainamide • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
Not provided
Minimum Volume
0.2 mL
Container
plain red‑top tube
Collection Instructions
collected 15 minutes prior to next dose; centrifuge within 30 minutes after draw
Storage Instructions
Refrigerate specimen after collection
Causes for Rejection
SST tube is not acceptable
Related Tests
Other tests from different labs that may be relevant
Procainamide and N-Acetylprocainamide, Serum
Mayo Clinic Lab
Procainamide, Serum or Plasma
Labcorp
Propafenone, Serum
Mayo Clinic Lab
Propafenone Quantitation, Serum or Plasma
ARUP Laboratories
Propafenone, Serum or Plasma
Labcorp
Amiodarone and Metabolite
ARUP Laboratories
Quinidine, Serum or Plasma
Labcorp
Amiodarone, Serum
Mayo Clinic Lab
Disopyramide, Serum or Plasma
Labcorp
Tocainide, Serum or Plasma
Labcorp